Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Mergers & Acquisitions
Gene expression company announces acquisition of Digital Gene Technologies
September 8th, 2004
Neurome, Inc., announced the purchase of substantially all the assets of Digital Gene Technologies, Inc., including the TOGA technology, gene expression assays, existing datasets and know-how related to vaccine development programs. In conjunction with the asset purchase, Neurome will also acquire the entire patent estate, which includes data and discoveries generated in commercial and academic research programs with leading researchers worldwide. The acquisition will allow Neurome to successfully expand beyond its current core technologies in quantitative molecular neuropathology to include TOGA's highly sensitive gene expression based surveys...
Source: Vaccine Weekly (2004-09-08)
|
